Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in Anemic Women with Uterine Fibroids
NCT00702702Phase 3Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telapristone in Uterine Fibroids (UF), anemia, sponsored by Repros Therapeutics Inc.. Started Jun 2008; status: terminated.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)anemia
Beyond the preview
Go deeper on NCT00702702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702702.